Coram Inc Specialty Infusion is categorized under Home Health Care Services in Columbia, MD .
Coram Inc Specialty Infusion was established in 0, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Home Health Care Services business, which does work in the B2C market, and is classified as a Home Health Care Services, under code number 6216100 by the NAICS.
If you are seeking more information, feel free to contact Michael Grimes, Manager at the company’s branch by writing to 7150 Columbia Gateway Drive, Columbia, Maryland MD 21046 or by phoning (410) 720-6501. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Coram Inc Specialty Infusion |
Contact Person: | Michael Grimes, Manager |
Address: | 7150 Columbia Gateway Drive, Columbia, Maryland 21046 |
Phone Number: | (410) 720-6501 |
Website Address: | coramhc.com |
Annual Revenue (USD): | $1.000.000 to $2.499.999 |
Location Type: | Branch |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Home Health Care Services |
SIC Code: | 8082 |
NAICS Code: | 6216100 |
Share This Business: |
Coram Inc Specialty Infusion was started in 0 to provide professional Home Health Care Services under the SIC code 8082 and NAICS code 6216100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Michael Grimes, Manager for inquiries that concern Coram Inc Specialty Infusion by calling the company number (410) 720-6501, as your correspondence is most welcome. Additionally, the physical location of the branch of Coram Inc Specialty Infusion can be found at the coordinates 39.17891,-76.80693 as well as the street address 7150 Columbia Gateway Drive in Columbia, Maryland 21046.
For its online presence, you may visit Coram Inc Specialty Infusion’s website at coramhc.com and engage with its social media outlets through on Twitter and on Facebook.